The homocysteine hypothesis: still relevant to the prevention and treatment of cardiovascular disease?
Where this comes from
- Record sourced from PubMed, PMID 21147945.
- Also identified by DOI 10.3949/ccjm.77a.10036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although evidence suggests that the homocysteine hypothesis is still relevant as a predictor of cardiovascular risk, we cannot conclude that measuring the homocysteine level is useful in guiding treatment. Furthermore, studies of primary and secondary prevention show no evidence that taking folic acid or other B vitamins lowers the risk of cardiovascular events.